Kelatorphan, a potent enkephalinases inhibitor, presents opposite properties when injected intracerebroventricularly or into the nucleus accumbens on intracranial self-stimulationHEIDBREDER, C; ROQUES, B; VANDERHAEGHEN, J. J et al.Neurochemistry international. 1988, Vol 12, Num 3, pp 347-350, issn 0197-0186Article

Enképhalines et analgésie = Enkephalins and analgesiaZAJAC, J.-M; DAUGE, V; DICKENSON, A.-H et al.Agressologie (Paris). 1988, Vol 29, pp 67-70, issn 0002-1148, no. sp. 2Conference Paper

Antinociceptive effect of systemic kelatorphan, in mononeuropathic rats, involves different opioid receptor typesSUN HAE LEE; KAYSER, V; GUILBAUD, G et al.European journal of pharmacology. 1994, Vol 264, Num 1, pp 61-67, issn 0014-2999Article

Potentiation of enkephalin action by peptidase inhibitors in rat locus ceruleus in vitroWILLIAMS, J. T; CHRISTIE, M. J; NORTH, R. A et al.The Journal of pharmacology and experimental therapeutics. 1987, Vol 243, Num 1, pp 397-401, issn 0022-3565Article

Prevention of degradation of endogenous enkephalins produces inhibition of nociceptive neurones in rat spinal cordDICKENSON, A. H; SULLIVAN, A. F; FOURNIE-ZALUSKI, M. C et al.Brain research. 1987, Vol 408, Num 1-2, pp 185-191, issn 0006-8993Article

Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cordBOURGOIN, S; LE BARS, D; ARTAUD, F et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 238, Num 1, pp 360-366, issn 0022-3565Article

Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naive mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexoneCRAIN, Stanley M; SHEN, Ke-Fei.Brain research. 2008, Vol 1231, pp 16-24, issn 0006-8993, 9 p.Article

Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respirationBOUDINOT, Eliane; MORIN-SURUN, Marie-Pierre; FOUTZ, Arthur S et al.Pain (Amsterdam). 2001, Vol 90, Num 1-2, pp 7-13, issn 0304-3959Article

Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplantsSAGEN, J; HONG WANG.European journal of pharmacology. 1990, Vol 179, Num 3, pp 427-433, issn 0014-2999Article

Effects of Kalatorphan and morphine before and after noxious stimulation on immediate-early gene expression in rat spinal cord neuronsTÖLLE, T. R; SCHADRACK, J; CASTRO-LOPES, J. M et al.Pain (Amsterdam). 1994, Vol 56, Num 1, pp 103-112, issn 0304-3959Article

Comparison of selective and complete inhibitors of enkephalin-degrading enzymes on morphine withdrawal syndromeMALDONADO, R; DAUGE, V; CALLEBERT, J et al.European journal of pharmacology. 1989, Vol 165, Num 2-3, pp 199-207, issn 0014-2999Article

Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective μ and δ opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymesDAUGE, V; ROSSIGNOL, P; ROQUES, B. P et al.Psychopharmacologia. 1988, Vol 96, Num 3, pp 343-352, issn 0033-3158Article

Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious testsSCHMIDT, C; PEYROUX, J; NOBLE, F et al.European journal of pharmacology. 1991, Vol 192, Num 2, pp 253-262, issn 0014-2999, 10 p.Article

Effect of peptidase inhibition on the pattern of instraspinally released immunoreactive substance P detected with antibody microprobesDUGGAN, A. W; SCHAIBLE, H.-G; HOPE, P. J et al.Brain research. 1992, Vol 579, Num 2, pp 261-269, issn 0006-8993Article

Potent antinociceptive effects of Kelatorphan (a highly efficient inhibitor of multiple enkephalin-degrading enzymes) systemically administered in normal and arthritic ratsKAYSER, V; FOURNIE-ZALUSKI, M. C; GUILBAUD, G et al.Brain research. 1989, Vol 497, Num 1, pp 94-101, issn 0006-8993Article

Evidence that endogenous enkephalins and a γ opioid receptor agonist have a common site of action in spinal antinociceptionDICKENSON, A. H; SULLIVAN, A. F; ROQUES, B. P et al.European journal of pharmacology. 1988, Vol 148, Num 3, pp 437-439, issn 0014-2999Article

Kelatorphan potentiates the effect of [Met⁵]enkephalin in the substantia gelatinosa of the cat spinal cordMORTON, C. R; ZHAO, Z.-Q; DUGGAN, A. W et al.European journal of pharmacology. 1987, Vol 140, Num 2, pp 195-201, issn 0014-2999Article

Kelatorphan, a potent enkephalinases inhibitior, and opioid receptor agonists DAGO and DTLET, differentially modulate self-stimulation behaviour depending on the site of administrationDE WITTE, P; HEIDBREDER, C; ROQUES, B. P et al.Neuropharmacology. 1989, Vol 28, Num 7, pp 667-676, issn 0028-3908Article

Chronic blockade of D₂ but not D₁ dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in ratsMALDONADO, R; DAUGE, V; FEGER, J et al.Neuropharmacology. 1990, Vol 29, Num 3, pp 215-223, issn 0028-3908Article

Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of δ and μ opioid receptorsDAUGE, V; ROSSIGNOL, P; ROQUES, B. P et al.Psychopharmacologia. 1989, Vol 99, Num 2, pp 168-175, issn 0033-3158Article